Priority will be given to letters less than 500 words long. Authors must sign the letter, which may be edited for reasons of space. Readers may now comment on letters via the BDJ website (www.bdj.co.uk). A 'Readers' Comments' section appears at the end of the full text of each letter online.
Sir, it has recently come to our attention that the capsules used in certain antibiotics (and also analgesics in capsule form) contain gelatine of animal origin. Details of capsule constituents is given in the patient information leaflet supplied with the medicine, but generally states simply 'gelatin' . This gelatine is generally derived from mixed porcine/ bovine sources, and as such may be unacceptable to some patients for religious or ethical reasons. Whilst some of these patients would be happy to take these antibiotics as a necessary medical treatment, others may choose not to do so -especially if an alternative is available. Note: this consideration is not present in tablet form antibiotics eg metronidazole, co-amoxiclav.
At least one brand of amoxicillin (Accord) supplies capsules of bovine-only, Halalcertified origin, but obtaining these specific antibiotics may be difficult or impossible. Obviously this still does not solve the problem for patients wishing to avoid products of bovine origin. NEWT guidelines (for administration of medication to patients with enteral feeding tubes or swallowing difficulties) 1 do not specify whether amoxicillin capsules can be opened and their contents dispersed, so this is perhaps inadvisable.
A feasible alternative to amoxicillin capsules is to prescribe suspension form. Amoxicillin is available in up to 250 mg/5 ml suspension: a 100 ml bottle costs £1.33, compared to £1.30 for 21 × 250 mg capsules, or £1.57 for 21 × 500 mg capsules. 2 Clindamycin capsules can be opened, but the NEWT guidelines suggest that the contents be dispersed in 'grape juice or maple syrup' due to the bad taste! Whether or not the patient would be happy to ingest contents which have been in contact with the gelatine-containing capsule should be discussed with them prior to prescription in these instances. Clindamycin is available in suspension in unlicensed form, so clinicians would likely need to discuss with the pharmacist whether dispensing this is possible. Clindamycin is therefore unlikely to be the antibiotic of choice in patients objecting to taking gelatine-based capsules.
As clinicians, we must inform our patients as to any risks of treatment that they may perceive as significant, and for many people, this may well include ingestion of porcine or bovine products. Patients should be fully informed about treatments and their alternatives; together with risks of declining treatment, in order to make an informed decision about their care. Clinicians may need to consider this when prescribing capsule-based medicines to their patients.
H. P. Beddis, Leeds 
REGULATION

Amused and frustrated
Sir, I was both amused and frustrated by an advert that appeared in the 25 March edition of the BDJ (vol. 220 issue 6). It was placed on behalf of the GDC which is seeking to recruit clinical case examiners and includes the following sentence: 'You will work efficiently and manage a large and varied workload, bringing high levels of accuracy and attention to detail' [my italics]. Further on in the advert the following appears: 'We regulate across the whole dental team -dentists, hygienists, Sir, I write in response to L. J. Brinton's request for the personal experiences of striking juniors in the junior doctors'/ dentists' contract dispute (BDJ 2016; 220; 323-324). The BDA, in offering its junior hospital members the opportunity to take part in industrial action, has not only acknowledged that the contract is unfair but has allowed us to show our support with the BMA and our medical colleagues. A unity rarely seen in dentistry. To celebrate strike action in similar format to the heartfelt voluntary efforts of Mr Sheikh and his colleagues 1 would be crass and insensitive. Indeed, no junior has taken the decision to participate in strike action lightly. I know I did not, it was the subject of much soul-searching but my patients were all very understanding.
Whilst short-term patient care may be affected by the strikes, it is my opinion that imposition of the new contract will adversely affect patient care by stretching an already stretched five-day elective NHS service to seven days without any additional staffing or funding. I feel it will also change the structure of the hospital profession overall, not only by normalising weekend hours, but it may act as a deterrent for those who are not able to work full time through maternity leave, parenthood or disability (the recently published equality impact statement openly admitting that women are more likely to be disadvantaged but is a 'proportionate means to a legitimate aim'). 2 The future of the NHS should be for long-term patient benefit, not short-term political goals.
Whilst I will soon be completing my training and will spend very little time under a new contract (if at all), I wish to ensure that the junior dentists that follow me have been represented by us, their predecessors, to the best of our ability to ensure a safe and fair contract for all. To use the BMA's tagline, it's everyone's fight. We are one profession. We stand together.
K. L. McDermott ('Junior Dentist'), Leeds
